Source: Hepatology. Conference titles: Annual Meeting of the American Association for the Study of Liver Diseases. Unidade: FM
Assunto: MEDICINA
ABNT
BASSIT, L et al. Genotype 2, rather than 1 and 3a, is predictive responsive factor to therapy in Brazilian patients with chronic hepatitis C infection. Hepatology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 04 out. 2024. , 1996APA
Bassit, L., Silva, L. C. da, Carrilho, F. J., Mendes, L. C. A., Fonseca, L. E. P., Pereira, A. L., et al. (1996). Genotype 2, rather than 1 and 3a, is predictive responsive factor to therapy in Brazilian patients with chronic hepatitis C infection. Hepatology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Bassit L, Silva LC da, Carrilho FJ, Mendes LCA, Fonseca LEP, Pereira AL, Alves VAF, Gayotto LC da C, Saez Alquezar A. Genotype 2, rather than 1 and 3a, is predictive responsive factor to therapy in Brazilian patients with chronic hepatitis C infection. Hepatology. 1996 ; 24( 4): 161A.[citado 2024 out. 04 ]Vancouver
Bassit L, Silva LC da, Carrilho FJ, Mendes LCA, Fonseca LEP, Pereira AL, Alves VAF, Gayotto LC da C, Saez Alquezar A. Genotype 2, rather than 1 and 3a, is predictive responsive factor to therapy in Brazilian patients with chronic hepatitis C infection. Hepatology. 1996 ; 24( 4): 161A.[citado 2024 out. 04 ]